Identifying candidate genes involved in osteoarthritis through bioinformatics analysis

Area of Science:

• Genomics
• Molecular Biology
• Biochemistry

Background:

• Osteoarthritis (OA) is a degenerative joint disease with complex genetic underpinnings.
• Identifying specific genes and molecular pathways is crucial for understanding OA pathogenesis and developing targeted therapies.

Purpose of the Study:

• To identify candidate genes and critical molecular pathways involved in the development of osteoarthritis (OA).
• To explore potential novel therapeutic targets for OA treatment.

Main Methods:

• Gene expression data from OA patients and normal controls were analyzed to identify differentially expressed genes (DEGs).
• Protein-protein interaction (PPI) networks were constructed to identify hub genes.
• Perturbation and pathway enrichment analyses were performed to elucidate critical molecular pathways.

Main Results:

• A total of 236 up-regulated and 290 down-regulated DEGs were identified.
• Ten hub genes, including VEGFA, IL6, and JUN, were identified in the PPI network.
• Pathway enrichment analysis revealed 176 significantly enriched pathways, with rheumatoid arthritis and osteoclast differentiation highlighted.

Conclusions:

• Rheumatoid arthritis, osteoclast differentiation, and cytokine-cytokine receptor interaction pathways are implicated in OA pathogenesis.
• Novel genes such as VEGFA, JUN, JUNB, PISD, RARRES3, EIF4G1, and EPHA3 may play significant roles in OA.
• These findings provide new directions for OA drug targeting and therapeutic strategies.